OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $149,775 | -20.0% | 13,231 | -0.9% | 0.00% | 0.0% |
| Q4 2023 | $187,230 | +13.1% | 13,345 | -0.4% | 0.00% | 0.0% |
| Q3 2023 | $165,478 | +41.8% | 13,399 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $116,686 | +116.1% | 12,922 | +1.4% | 0.00% | – |
| Q1 2022 | $54,000 | -56.8% | 12,739 | -4.8% | 0.00% | -100.0% |
| Q4 2021 | $125,000 | -67.1% | 13,388 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $380,000 | +100.0% | 13,790 | +102.9% | 0.00% | +100.0% |
| Q2 2021 | $190,000 | -19.1% | 6,796 | -3.9% | 0.00% | 0.0% |
| Q1 2021 | $235,000 | – | 7,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |